MedTrace Logo

RESCEU: Defining the Burden of RSV Disease

NCT03698084 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-10-27

No results posted yet for this study

Summary

This observational study will determine the burden of RSV disease in at least 2000 healthy infants over 6 years until November 2026. The study will determine the incidence of acute respiratory tract infection (ARTI) associated with RSV, of medically attended ARTI and RSV related hospitalisation.

Mortality (RSV associated and all-cause) through all RSV seasons and the health care costs, resource use and Health Related Quality of Life will also be determined. The study also aims to determine important risk factors for RSV infection (by severity and healthcare utilisation.

Conditions

  • Respiratory Syncytial Virus Infections
  • RSV Infection

Interventions

PROCEDURE

venepuncture

sample collection for analysis

PROCEDURE

nasopharyngeal swab

sample collection for analysis

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03698084 on ClinicalTrials.gov